Amyloidosis: Public Comment on Draft Report

Public comments received on ICER’s Draft Evidence Report on hereditary transthyretin-related amyloidosis.

View

View All Materials on this Topic or Go Back to View More Materials

EMAIL SIGNUP

Stay up-to-date on the latest news from ICER.
© ICER, 2020.

CONTACT US

Institute for Clinical and Economic Review
Two Liberty Square, Ninth Floor, Boston, MA 02109
Get directions.

(617) 528-4013

STAY CONNECTED

To ensure that our reports are as useful as possible to our stakeholders, we would like to get a better sense of how they are being used. You will be redirected to the report after answering these brief questions.

Which category best describes your perspective?*
Other
How do you intend to use this material*
Please check all that apply.
- To inform treatment decisions or guidelines
- To inform state policy
- To inform federal policy
- To inform public comment/feedback to ICER
- To inform coverage decisions and contracting policies
- To inform pricing
- Other
If Other, please describe

We use cookies to ensure that we give you the best experience on our website. By closing this banner, scrolling this page, clicking a link, or continuing to browse this site, you agree to this use.Ok Privacy policy